Long-Term Feasibility of 13.56 MHz Modulated Electro-Hyperthermia-Based Preoperative Thermoradiochemotherapy in Locally Advanced Rectal Cancer

Long-Term Feasibility of 13.56 MHz Modulated Electro-Hyperthermia-Based Preoperative Thermoradiochemotherapy in Locally Advanced Rectal Cancer

We evaluated the effect of 13.56 MHz modulated electro-hyperthermia (mEHT) boost in neoadjuvant treatment for cT3-4- or cN-positive rectal cancer. Sixty patients who completed the mEHT feasibility trial (ClinicalTrials.gov Identifier: NCT02546596) were analyzed. Whole pelvis radiotherapy of 40 Gy, m...

Full description

Bibliographic Details
Main Authors: Yohan Lee, Sunghyun Kim, Hyejung Cha, Jae Hun Han, Hyun Joon Choi, Eun Go, Sei Hwan You
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
regional hyperthermia
rectal cancer
neoadjuvant chemoradiation
survival
Online Access:https://www.mdpi.com/2072-6694/14/5/1271

Internet

https://www.mdpi.com/2072-6694/14/5/1271

Similar Items